Trial Innovation Network
- Trial Innovation Network
Introduction: During the COVID-19 pandemic, many research participants cannot be consented in person, thereby making it critical to have a consent document that provides a clear presentation of key information to help someone make a decision about study participation. We utilized a community-engaged approach to technology development to inform features within the REDCap software platform to
-Trial Innovation NetworkImplementing your research project within an Electronic Health Record (EHR) system is an exciting but complex endeavor that requires specialized tools and approaches. This talk will unpack what dedicated teams of informaticians have pioneered over the past decade. It will help the researcher understand a path forward for their research protocols. The talk addresses key differences between
-
-Trial Innovation NetworkThe NIA staff will discuss some of the limitations with inclusion of diverse populations observed in clinical research and trials, the role federal science policy is playing in remedying the limitations and promoting more broad and consistent inclusion of communities of color in developing new strategies implemented to enhance inclusion among older persons of color. The NIA team will provide an
-
Vanderbilt University Medical CenterTrial Innovation Network
This webinar will provide a brief overview of REDCap’s eConsent functionality along with considerations about Part-11 validation. Special emphasis will also be place on 2-part consenting and multi-site trials. Resources will be provided where teams can get more information and begin to build out their own consents. Presenters: Paul Harris, PhD & Colleen Lawrence, PhD This presentation was
Trial Innovation NetworkThe Trial Innovation Network (TIN) is an established partnership with the CTSA Program, the National Center for Advancing Translational Science (NCATS), and other NIH Institutes and Centers. Currently (AUG 2019) the TIN is supporting 212 projects, including 134 active studies that represent 59 therapeutic areas. These projects create opportunities for the CTSA Program Hubs, the Trial Innovation